This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Wael M Badawy | |
---|---|
File:Waelbadawy.jpg | |
Born | |
Occupation(s) | Chairman, IntelliView Technologies Inc |
Website | Personal Website |
Wael Badawy (Arabic: بدوى; born in Alexandria, Egypt) is an entrepreneur, inventor, political activist, and writer.
Biography
editDr. Wael Badawy is a member of APEGGA [1]. Dr. Badawy conducted his research at the U of Calgary, Canada where he was an iCore Chair Associate. He received the Standard Council of Canada, Award of Excellence [2]. He is Named in the [Top 40 under 40], [Avenue Magazine] [[3]] [[4]] [[5]]. He is honored with the Distinguished Professional Awards by Immigrant Services Calgary [[6]] In 2009, honored and named as Microsoft’s Canadian Innovator Program, where Canadian men and women are using technology to create breakthroughs that benefit people across the country [7]. In 2009, he received Certificate of Appreciation, on behalf of ISO and IEC [[8]], to acknowledge with appreciation the special contribution made as a project editor in the development of International Standard. ISO/IEC TR 14496-9:2008, Information technology – Coding of audio-visual objects – Part 9: Reference hardware description.
Personal life
editPublished work
editYehya Ghallab and Wael Badawy, Lab-on-a-chip, Techniques, Circuits, and Biomedical Applications, Artech House, ISBN: 1-59693-418-2, July 2010.
Wael Badawy and G. Jullien, System on Chip for RT Applications, Kluwer Publisher, ISBN 1-4020-7254-6.
External links
edit- Personal website http://www.badawy.ca
- [9] http://www.wired.com/medtech/health/news/2003/07/59761
- [10] http://www.theengineer.co.uk/news/sick-sense/278363.article
- [11] http://www.ihealthbeat.org/articles/2003/7/28/ipill-determines-correct-dose.aspx
- [12] http://www.pharmainfo.net/publications/view/116885